Long-term Survival Outcome of Surgery versus Stereotactic Body Radiation Therapy as Initial Local Treatment for Pulmonary Oligometastases from Colorectal Cancer

Drew Moghanaki shared a post on X about a paper by Yaqi Wang et al. published in International Journal of Radiation Oncology, Biology, Physics.

“’The long-term survival of patients with CRC pulmonary oligometastases did not depend on the initial choice of the local treatment approach.’”

Comparison of the Long-term Survival Outcome of Surgery versus Stereotactic Body Radiation Therapy as Initial Local Treatment for Pulmonary Oligometastases from Colorectal Cancer: A Propensity Score Analysis

Authors: Yaqi Wang, MD, Xin Dong, MD, Shi Yan, MD, Bing Liu, MD, Xiang Li, MD, Shaolei Li, MD, Chao Lv, MD, Xinrun Cui, MD, Ye Tao, MD, Rong Yu, MD, Nan Wu, MD

Source: Drew Moghanaki/X

Dr. Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university.

He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).